<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Neuroprotective Small Molecule TrkB Agonist</title>
	<atom:link href="http://drugdiscoveryopinion.com/2010/01/neuroprotective-small-molecule-trkb-agonist/feed/" rel="self" type="application/rss+xml" />
	<link>http://drugdiscoveryopinion.com/2010/01/neuroprotective-small-molecule-trkb-agonist/</link>
	<description>DDO Limited - Consultancy for Biotech and Pharma</description>
	<lastBuildDate>Fri, 06 Jan 2012 16:31:48 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=</generator>
	<item>
		<title>By: dr.umesh</title>
		<link>http://drugdiscoveryopinion.com/2010/01/neuroprotective-small-molecule-trkb-agonist/comment-page-1/#comment-1594</link>
		<dc:creator>dr.umesh</dc:creator>
		<pubDate>Fri, 29 Jan 2010 04:50:32 +0000</pubDate>
		<guid isPermaLink="false">http://drugdiscoveryopinion.com/?p=2053#comment-1594</guid>
		<description>Its good to see the diverse activity associated with 7,8-Dihydroxyflavone. I think  for Amyotrophic Lateral Sclerosis (Lou Gehrig&#039;s Disease), Riluzole is advised with very little success like slow down ALS, patients do not report any subjective improvement....</description>
		<content:encoded><![CDATA[<p>Its good to see the diverse activity associated with 7,8-Dihydroxyflavone. I think  for Amyotrophic Lateral Sclerosis (Lou Gehrig&#8217;s Disease), Riluzole is advised with very little success like slow down ALS, patients do not report any subjective improvement&#8230;.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

